MedCity News July 16, 2020
John Dobak

Naysayers have been proven wrong multiple times over as companies across the biotech industry have advanced to deliver diagnostics and detection assays across a number of different cancer types enabling predictive testing, early diagnosis and objective results.

At the time when Microsoft announced Windows in 1985, it would have been hard to believe how quickly personal computers would become ubiquitous. During that same period, biotechnology was experiencing a parallel wave. When the Human Genome Project started in 1990, sequencing the human genome for the first time was accomplished through an international effort over the course of 13 years. Four years later, a similar sequencing project was completed in just two months.

Today, researchers and practitioners are leveraging the decoded information...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Estonian Biobank to Sequence 10,000 Genomes as Part of Precision Medicine Project
Precision Immune Start-Up Mirador Launches with $400M+
The future of companion diagnostic (CDx) development: Why commercialization is key
STAT+: Drug development was once a marathon. New tools and timelines are turning it into a sprint
Precision Medicine Startup Mirador Unveils $400M for R&D of New I&I Drugs

Share This Article